Anaesthesia drugs worst-hit by US drug shortages
An analysis of FDA data shows the majority of drugs in short supply in the US are anaesthetics.
By
Supply Chain
Latest in
Supply Chain
Digitising the pharma supply chain
The Covid-19 pandemic has highlighted the need for security and traceability at every step of the drug supply chain.
By
The dark consequences of drug supply shortages
Drug shortages caused by supply chain issues or political decisions can open the door to illicit online pharmacies.
By
Global warning: pharma’s role in the climate crisis
With COP26 imminent, what lessons can the pharma sector learn about its environmental impact and its response to climate change?
By
Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
By
Covid-19: vaccine pricing varies wildly by country and company
As the vaccine inequity debate rages on, even nations with access to Covid-19 jabs are paying wildly different prices for…
By
Pharma’s reliance on horseshoe crabs is threatening the species
Conservationists say using the prehistoric creatures’ blood for bacterial endotoxin testing is no longer justifiable.
By
ICON Q&A: talking affordability in cell and gene therapies
ICON’s Tamie Joeckel discusses the challenges of making cell and gene therapies affordable for payers and patients alike.
By